עקוב אחר
shima salimi
shima salimi
Middle East Liver Disease Center
כתובת אימייל מאומתת בדומיין meldcenter.com - דף הבית
כותרת
צוטט על ידי
צוטט על ידי
שנה
Development and validation of a simple, rapid and inexpensive PCR-RFLP method for genotyping of common IL28B polymorphisms: a useful pharmacogenetic tool for prediction of …
H Sharafi, A Pouryasin, SM Alavian, B Behnava, M Keshvari, ...
Hepatitis Monthly 12 (3), 190, 2012
542012
Effectiveness of methadone maintenance treatment in prevention of hepatitis C virus transmission among injecting drug users
SM Alavian, A Mirahmadizadeh, M Javanbakht, A Keshtkaran, A Heidari, ...
Hepatitis monthly 13 (8), 2013
462013
Distribution of IL28B genotypes in Iranian patients with chronic hepatitis C and healthy individuals
H Sharafi, A Pouryasin, SM Alavian, B Behnava, M Keshvari, S Salimi, ...
Hepatitis Monthly 12 (12), 2012
402012
Associations between human TRIM22 gene expression and the response to combination therapy with Peg‐IFNα‐2a and ribavirin in Iranian patients with chronic hepatitis C
F Sadeghi, F Bokharaei‐Salim, M Salehi‐Vaziri, SH Monavari, ...
Journal of medical virology 86 (9), 1499-1506, 2014
312014
The role of polymorphisms near the IL28B gene on response to peg-interferon and ribavirin in thalassemic patients with hepatitis C
B Behnava, H Sharafi, M Keshvari, A Pouryasin, L Mehrnoush, S Salimi, ...
Hepatitis Monthly 16 (1), 2016
242016
Efficacy of prolonged treatment with pegylated interferon (Peg-IFN) and ribavirin in thalassemic patients with hepatitis C who relapsed after previous Peg-IFN-based therapy
S Sandoughdaran, SM Alavian, H Sharafi, B Behnava, S Salimi, ...
Hepatitis Monthly 15 (1), 2015
232015
The prevalence of hepatitis C virus core amino acid 70 substitution and genotypes of polymorphisms near the IFNL3 gene in Iranian patients with chronic hepatitis C
D Kadjbaf, M Keshvari, SM Alavian, A Pouryasin, B Behnava, S Salimi, ...
Hepatitis monthly 16 (6), 2016
192016
Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?
S Sali, H Sharafi, SH Alavian, SM Alavian, F Etesam, S Salimi, MA Merza, ...
Diagnostic microbiology and infectious disease 82 (2), 114-119, 2015
152015
Effect of zinc supplementation on viral response in patients with chronic hepatitis C and Beta thalassemia major, a pilot study
M Abbasinazari, SM Alavian, B Behnava, M Asgharinia, S Salimi, ...
Journal of clinical and diagnostic research: JCDR 8 (12), HC16, 2014
152014
Mysterious Linkages Between Hepatitis C Virus Genotypes, Interleukin-28B Genotypes and Viral Clearance-A Meta-Analysis
SH Aalaei-Andabili, B Behnava, S Salimi, H Sharafi, SM Alavian
Hepatitis monthly 14 (3), 2014
152014
Impact of the IL-10 promoter gene polymorphisms in the severity of chronic hepatitis B infection
SG Baghi, SM Alavian, L Mehrnoush, S Salimi
Hepatitis monthly 15 (7), 2015
132015
Efficacy and tolerability of peginterferon alpha-2a and peginterferon alpha-2b in Iranian patients with chronic hepatitis C
M Pouresmaeeli, SM Alavian, M Keshvari, S Salimi, L Mehrnoush
Hepatitis Monthly 15 (9), 2015
122015
The seroprevalence of entrically transmitted viral hepatitis in HCV infected thalassemia and hemophilia patients in Iran
PK Elizee, SM Alavian, SM Miri, B Behnava, SH Alavian, M Keshvari, ...
Jundishapur Journal of Microbiology 6 (7), 6, 2013
112013
Assessment of Hepatitis C Virus RNA in Peripheral Blood Mononuclear Cells as a Predictor of Response to Pegylated-Interferon and Ribavirin: A Cohort Study.
SM Miri, H Sharafi, S Salimi, F Bokharaei-Salim, B Behnava, M Keshvari, ...
Iranian Red Crescent Medical Journal 19 (5), 2017
92017
Prognostic values of fluctuations in serum levels of alanine transaminase in inactive carrier state of HBV infection
H Farzi, NE Daryani, L Mehrnoush, S Salimi, SM Alavian
Hepatitis Monthly 14 (5), 2014
72014
Plasma zinc level in hepatitis C patients with or without Beta thalassemia major; is there any difference?
M Abbasinazari, B Behnava, Y Panahi, AH Talasaz, S Salimi, M Keshvari, ...
Hepatitis Monthly 13 (8), 2013
72013
Liver hemangioma might lead to overestimation of liver fibrosis by Fibroscan; a missed issue in two cases
SH Aalaei-Andabili, L Mehrnoush, S Salimi, M Shafiei, SM Alavian
Hepatitis Monthly 12 (6), 408, 2012
62012
Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders
H Sharafi, B Behnava, A Azizi-Saraji, A Namvar, A Anvar, S Salimi, ...
Virology Journal 18, 1-10, 2021
52021
The role of polymorphisms Near IFNL3 gene as predictors of residual HCV RNA in buffy coat after successful antiviral therapy
SM Miri, H Sharafi, A Pouryasin, B Behnava, M Keshvari, S Salimi, ...
Hepatitis Monthly 17 (4), 6, 2017
42017
High response rate to pegylated interferon alpha and ribavirin combination therapy in hemophilic children with chronic hepatitis C; a case-control study
L Mehrnoush, SM Alavian, H Sharafi, B Behnava, S Salimi, M Keshvari
Pediatric Hematology and Oncology 32 (6), 399-405, 2015
42015
המערכת אינה יכולה לבצע את הפעולה כעת. נסה שוב מאוחר יותר.
מאמרים 1–20